Adverum Biotechnologies, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Adverum Biotechnologies, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2013 to Q2 2024.
  • Adverum Biotechnologies, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $2.41M, a 52.7% increase year-over-year.
  • Adverum Biotechnologies, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $7.43M, a 51% increase year-over-year.
  • Adverum Biotechnologies, Inc. annual Nonoperating Income (Expense) for 2023 was $5.75M, a 115% increase from 2022.
  • Adverum Biotechnologies, Inc. annual Nonoperating Income (Expense) for 2022 was $2.67M, a 359% increase from 2021.
  • Adverum Biotechnologies, Inc. annual Nonoperating Income (Expense) for 2021 was $582K, a 62.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.43M $2.41M +$830K +52.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $6.6M $2.05M +$852K +71% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.75M $1.31M +$88K +7.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 $5.66M $1.66M +$738K +80% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.92M $1.58M +$1.29M +457% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $3.63M $1.2M +$956K +392% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.67M $1.22M +$1.21M +12130% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $1.46M $923K +$763K +477% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $697K $283K +$78K +38% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $619K $244K +$37K +17.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $582K $10K +$148K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $434K $160K -$75K -31.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $509K $205K -$370K -64.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $879K $207K -$678K -76.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.56M -$138K -$866K -119% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $2.42M $235K -$730K -75.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $3.15M $575K -$573K -49.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $3.73M $885K -$333K -27.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $4.06M $728K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $965K -$300K -23.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.15M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.22M +$472K +63.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
Q3 2018 $1.27M +$523K +70.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q1 2018 $2.96M $746K +$257K +52.6% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $2.7M $806K +$588K +270% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-06
Q3 2017 $2.11M $742K +$536K +260% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $1.58M $663K +$441K +199% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $1.14M $489K +$373K +322% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $762K $218K +$133K +156% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 $629K $206K +$89K +76.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $540K $222K +$106K +91.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $434K $116K +$64K +123% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $370K $85K +$73K +608% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 $297K $117K +$433K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$136K $116K +$757K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$893K $52K +$109K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$1M $12K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 -$316K -$281K -803% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$641K -$625K -3906% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$57K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q3 2013 -$35K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$16K Apr 1, 2013 Jun 30, 2013 10-Q 2014-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.